BROWN UNIVERSITY
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1764-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.brown.edu
Clinical Trials
272
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (266 trials with phase data)• Click on a phase to view related trials
Generalization and Specificity of Visual Learning During Sleep
- Conditions
- Visual LearningHealthy Volunteers
- First Posted Date
- 2025-06-11
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Brown University
- Target Recruit Count
- 10
- Registration Number
- NCT07015840
- Locations
- 🇺🇸
Brown University, Providence, Rhode Island, United States
Head and Neck Cancer Study Project in the Geriatric Population
- Conditions
- Head and Neck Neoplasms
- Interventions
- Drug: Arm II Carboplatin, Paclitaxel, CetuximabDrug: Arm I Carboplatin, Paclitaxel, PembrolizumabDrug: Arm III Pembrolizumab
- First Posted Date
- 2025-05-31
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Brown University
- Target Recruit Count
- 20
- Registration Number
- NCT06998069
- Locations
- 🇺🇸
Rhode Island and The Miriam Hospitals, Providence, Rhode Island, United States
Healthy Start: Family Childcare Providers and Parents
- Conditions
- Child ObesityNutrition, Healthy
- First Posted Date
- 2025-05-18
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- Brown University
- Target Recruit Count
- 40
- Registration Number
- NCT06978270
Promoting Physical Activity and Healthy Eating in Latinas
- Conditions
- Physical InactivtyPhysical ActivityDiet Quality
- First Posted Date
- 2025-05-18
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- Brown University
- Target Recruit Count
- 70
- Registration Number
- NCT06979297
- Locations
- 🇺🇸
Brown University, Providence, Rhode Island, United States
Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
- Conditions
- Breast NeoplasmsLung Neoplasms
- Interventions
- First Posted Date
- 2025-05-16
- Last Posted Date
- 2025-06-22
- Lead Sponsor
- Brown University
- Target Recruit Count
- 60
- Registration Number
- NCT06974604
- Locations
- 🇺🇸
Rhode Island and the Miriam Hospitals (Brown University Health), Providence, Rhode Island, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 55
- Next
News
Breakthrough Nanotechnology: Targeted Liposomes Dramatically Enhance Antifungal Treatment Against Resistant Candida
Brown University researchers have developed peptide-decorated liposomes that specifically target Candida cells, dramatically increasing antifungal drug effectiveness while sparing healthy human cells.
Excessive Sedentary Time Linked to Increased Cardiovascular Risk, Even in Active Individuals
New research reveals that more than 10.6 hours of daily sedentary behavior significantly increases risk of heart failure and cardiovascular mortality, even among those meeting exercise guidelines.
Infant Mortality Rises in States with Abortion Bans, New JAMA Studies Reveal
States enforcing abortion bans after the Dobbs decision experienced a 6% overall increase in infant mortality rates, resulting in 478 additional infant deaths compared to pre-ban projections.
Study Reveals Critical Gap: Less Than 1% of US Clinical Trials Include Pregnant Participants
A comprehensive analysis of ClinicalTrials.gov data shows that only 0.8% of 44,160 randomized controlled trials included pregnant participants, while 75% explicitly excluded them.
Ocean Biomedical's Novel Cancer Immunotherapy Shows Promise in Reversing EGFR-TKI Resistance in Lung Cancer
Ocean Biomedical's breakthrough research demonstrates their immunotherapy candidates can synergize with tyrosine kinase inhibitors like osimertinib to suppress tumor growth in EGFR-mutant lung cancer.